首页> 美国政府科技报告 >Clinical Importance of the Drug Interaction between Statins and CYP3A Inhibitors. Inclusive Dates: 07/01/08 - 06/30/10.
【24h】

Clinical Importance of the Drug Interaction between Statins and CYP3A Inhibitors. Inclusive Dates: 07/01/08 - 06/30/10.

机译:他汀类药物与CYp3a抑制剂药物相互作用的临床意义。包容性日期:07/01/08 - 06/30/10。

获取原文

摘要

The purpose of the current investigation was to detect adverse clinical outcomes associated with statins and CYP3A4 inhibitors. Our specific aim was to measure the relative hazard of muscle toxicity, kidney dysfunction, and hepatic dysfunction associated with statin 3A4 substrates compared to statin non-3A4 substrates with and without CYP3A4 inhibitor concomitancy.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号